These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23681193)

  • 41. Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2).
    Chen K; Wang JL; Huang SY; Yang WB; Zhu WN; Zhu XQ
    Parasite; 2017; 24():41. PubMed ID: 29119944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxoplasma gondii metacaspase 2 is an important factor that influences bradyzoite formation in the Pru strain.
    Song X; Lin M; Li M; Yang X; Liu J; Liu Q
    Parasitol Res; 2020 Jul; 119(7):2287-2298. PubMed ID: 32468190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.
    Liu Y; Cao A; Li Y; Li X; Cong H; He S; Zhou H
    BMC Infect Dis; 2017 Jun; 17(1):403. PubMed ID: 28592247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclin-dependent kinase TPK2 is a critical cell cycle regulator in Toxoplasma gondii.
    Khan F; Tang J; Qin CL; Kim K
    Mol Microbiol; 2002 Jul; 45(2):321-32. PubMed ID: 12123447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion.
    Skariah S; McIntyre MK; Mordue DG
    Parasitol Res; 2010 Jul; 107(2):253-60. PubMed ID: 20514494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. During host cell traversal and cell-to-cell passage, Toxoplasma gondii sporozoites inhabit the parasitophorous vacuole and posteriorly release dense granule protein-associated membranous trails.
    Tartarelli I; Tinari A; Possenti A; Cherchi S; Falchi M; Dubey JP; Spano F
    Int J Parasitol; 2020 Nov; 50(13):1099-1115. PubMed ID: 32882286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening.
    Deng Y; Wu T; Zhai SQ; Li CH
    Eur J Med Chem; 2019 Dec; 183():111711. PubMed ID: 31585276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein kinase TgCDPK7 regulates vesicular trafficking and phospholipid synthesis in Toxoplasma gondii.
    Bansal P; Antil N; Kumar M; Yamaryo-Botté Y; Rawat RS; Pinto S; Datta KK; Katris NJ; Botté CY; Prasad TSK; Sharma P
    PLoS Pathog; 2021 Feb; 17(2):e1009325. PubMed ID: 33635921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxoplasma gondii cyclic GMP-dependent kinase: chemotherapeutic targeting of an essential parasite protein kinase.
    Donald RG; Allocco J; Singh SB; Nare B; Salowe SP; Wiltsie J; Liberator PA
    Eukaryot Cell; 2002 Jun; 1(3):317-28. PubMed ID: 12455981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxoplasma gondii within skeletal muscle cells: a critical interplay for food-borne parasite transmission.
    Swierzy IJ; Muhammad M; Kroll J; Abelmann A; Tenter AM; Lüder CG
    Int J Parasitol; 2014 Feb; 44(2):91-8. PubMed ID: 24184158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A single mutation in the gatekeeper residue in TgMAPKL-1 restores the inhibitory effect of a bumped kinase inhibitor on the cell cycle.
    Sugi T; Kawazu S; Horimoto T; Kato K
    Int J Parasitol Drugs Drug Resist; 2015 Apr; 5(1):1-8. PubMed ID: 25941623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioinformatics analysis of calcium-dependent protein kinase 4 (CDPK4) as Toxoplasma gondii vaccine target.
    Foroutan M; Ghaffari AD; Soltani S; Majidiani H; Taghipour A; Sabaghan M
    BMC Res Notes; 2021 Feb; 14(1):50. PubMed ID: 33549149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclic nucleotide signaling in Toxoplasma gondii bradyzoite differentiation.
    Kirkman LA; Weiss LM; Kim K
    Infect Immun; 2001 Jan; 69(1):148-53. PubMed ID: 11119500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
    Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2008 Oct; 76(8):958-66. PubMed ID: 18755159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of the mitogen-activated protein (MAP) kinase signalling pathway in host cell invasion by Toxoplasma gondii.
    Robert-Gangneux F; Creuzet C; Dupouy-Camet J; Roisin MP
    Parasite; 2000 Jun; 7(2):95-101. PubMed ID: 10887655
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Sugi T; Tu V; Ma Y; Tomita T; Weiss LM
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of the host on
    Lüder CGK; Rahman T
    Microb Cell; 2017 Jun; 4(7):203-211. PubMed ID: 28706936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting
    Palencia A; Bougdour A; Brenier-Pinchart MP; Touquet B; Bertini RL; Sensi C; Gay G; Vollaire J; Josserand V; Easom E; Freund YR; Pelloux H; Rosenthal PJ; Cusack S; Hakimi MA
    EMBO Mol Med; 2017 Mar; 9(3):385-394. PubMed ID: 28148555
    [No Abstract]   [Full Text] [Related]  

  • 59. In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.
    Winzer P; Müller J; Aguado-Martínez A; Rahman M; Balmer V; Manser V; Ortega-Mora LM; Ojo KK; Fan E; Maly DJ; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6361-74. PubMed ID: 26248379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toxoplasma gondii attachment to host cells is regulated by a calmodulin-like domain protein kinase.
    Kieschnick H; Wakefield T; Narducci CA; Beckers C
    J Biol Chem; 2001 Apr; 276(15):12369-77. PubMed ID: 11154702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.